Recent Advances in RP-HPLC Methods for Estimating Pharmaceutical Combinations: Focus on Tadalafil and Losartan Potassium
Abstract
Recent developments in the RP-HPLC methodology aimed at determining drug combinations with special emphasis on tadalafil and losartan potassium monitoring are the subject of this research study. Tadalafil and losartan potassium receive medical usage for managing benign prostatic hyperplasia (BPH) as well as hypertension and practitioners commonly prescribe them together to treat patients with multiple health conditions. The paper demonstrates how RP-HPLC functions as the optimal analytical tool because it delivers highly precise and reproducible drug separation and quantification methods for pharmaceutical compositions. This research work provides comprehensive information about method validation parameters alongside discussions of method development including accuracy and precision alongside linearity testing and application of RP-HPLC for pharmaceutical formulations analysis. The evaluation explains analytical limitations because the technique needs both selectivity and sensitivity in drug detection along with strategies for optimization. This study concludes that RP-HPLC demonstrates successful reliability as a routine analysis method but needs additional improvements to optimize its efficiency in pharmaceutical investigations.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.